Intellia Therapeutics, Inc. (NASDAQ:NTLA) Receives Average Rating of "Hold" from Analysts
MarketBeat
Intellia Therapeutics, Inc. (NASDAQ:NTLA - Get Free Report) has earned a consensus recommendation of "Hold" from the twenty-three analysts that are covering the company, MarketBeat reports. Four research analysts have rated the stock with a sell rating, eight have assigned a hold rating, ten have
NASDAQ:NTLA